Wei Wei Prior

Wei Wei Prior has extensive work experience in the field of biotherapeutics and pharmaceutical research. Wei Wei began their career in 1992 at DNAX Research Institute, where they held the role of SRA for four years. Wei Wei then worked at Cell Genesys as an SRA from 1996 to 1998. After that, Wei Wei joined Systemix as an SRAIII from 1998 to 2000. Wei Wei then returned to Cell Genesys and worked as an SRA from 2001 to 2005.

In 2005, Wei Wei joined Genentech as an SRA, and they stayed with the company for seven years until 2012. At that point, they moved to OncoMed Pharmaceuticals and served as an SRA for one year. In 2014, Wei Wei joined Pfizer as a Research Scientist, where they worked until 2018.

Currently, Wei Wei Prior holds the position of Senior Scientist II and Head of In Vivo Core Group at QLSF Biotherapeutics, Inc., a role they began in July 2018. Overall, they have a diverse background in scientific research and has worked in various roles within the biotechnology and pharmaceutical industries.

Wei Wei Prior received a Master of Science (M.S.) and Medical Doctor (M.D.) degree in Medicine and Biology from a Medical School in China and SF State University in the United States. The specific start and end years for Wei Wei's education were not provided.